NEFL and myeloid sarcoma: Current evidence suggests that neurofilament heavy and light chain proteins (NfH and NfL, respectively) concentrations are increased in the CSF of MS patients compared to age-matched normal controls, although they do not reach the levels observed in neurodegenerative and more disruptive CNS disorders.